HIV阳性女性中HPV型别的致癌性:从感染到宫颈癌的荟萃分析
该研究系统检索并荟萃分析了全球86项研究中19883例HIV阳性女性的高危HPV型别分布,涵盖正常细胞学至浸润性宫颈癌各阶段。结果显示HPV 16、18和45在浸润性宫颈癌中占比显著高于正常细胞学,尤以非洲人群为著,提示部分HPV基因分型检测的风险分层也适用于HIV阳性女性。
要点
- 在非洲HIV阳性女性中,HPV 16在正常细胞学中占13%,在CIN3和浸润性宫颈癌中升至41%-47%。
- 仅HPV 16、18和45在浸润性宫颈癌中的占比高于正常细胞学,ICC:正常比值分别为3.68、2.47和2.55。
- 其他高危型别在低/高级别病变中占一定比例,但在浸润性宫颈癌中贡献下降,非洲ICC:正常比值从HPV 33的0.79降至HPV 56的0.38。
核心结论
- HPV 16和18尤其值得关注,HPV 45至少在非洲也需特别重视,应纳入HIV阳性女性的预防策略。
- 研究结果与HIV阴性人群广泛一致,提示部分HPV基因分型检测的风险分层对HIV阳性女性也有参考价值。
研究设计与样本
- 系统文献综述与荟萃分析,纳入全球86项研究、19883例HIV阳性女性。
- 细胞学诊断:正常11739例、ASCUS 1784例、低级别2173例、高级别1282例;组织学诊断:CIN1 1198例、CIN2 456例、CIN3 455例;浸润性宫颈癌796例。
- 大部分HIV阳性女性及几乎所有浸润性宫颈癌病例来自非洲。
主要发现
- 在非洲,HPV 16占HPV阳性且细胞学正常者的13%,经ASCUS、低级别病变、CIN1和CIN2升至18%-25%,在CIN3和浸润性宫颈癌中达41%-47%。
- 仅HPV 16、HPV 18和HPV 45在浸润性宫颈癌中的占比高于正常细胞学,ICC:正常比值分别为3.68、2.47和2.55。
- 其他高危型别在低和/或高级别病变中占重要比例,但在浸润性宫颈癌中贡献下降,非洲ICC:正常比值从HPV 33的0.79降至HPV 56的0.38。
- HPV 16和HPV 18在欧洲/北美、亚洲和拉丁美洲的发现与非洲一致。
临床怎么用
- 对HIV阳性女性进行HPV部分基因分型检测时,应重点关注HPV 16、18和45的阳性结果以评估宫颈癌风险。
- 非洲HIV阳性女性的HPV 16在高级别病变和浸润性宫颈癌中占比显著升高,筛查策略需考虑型别分布特征。
局限性
- 大部分HIV阳性女性及几乎所有浸润性宫颈癌病例来自非洲,其他地区数据有限。
- 原文未报告各研究间的异质性、发表偏倚等荟萃分析细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on the relative carcinogenic potential of human papillomavirus (HPV) types among women infected with human immunodeficiency virus (HIV) (WHIV) are needed to inform prevention programs for this population. METHODS: A systematic literature review and meta-analysis of high-risk HPV-type distribution in 19883 HIV-positive women was performed. The women, from 86 studies worldwide, included 11739 with normal cytological findings; 1784 with atypical squamous cells of undetermined significance (ASCUS); 2173 with low-grade and 1282 with high-grade squamous intraepithelial lesions (HSILs) diagnosed cytologically; 1198 with cervical intraepithelial neoplasia grade 1 (CIN1), 456 with CIN2, and 455 with CIN3 diagnosed histologically; and 796 with invasive cervical cancers (ICCs). A large proportion of WHIV, and almost all with ICCs, were from Africa. RESULTS: In Africa, HPV 16 accounted for 13% of HPV-positive WHIV with normal cytological findings, but this proportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (18%-25%), up to 41%-47% for CIN3 and ICCs. Only HPV 16, HPV 18, and HPV 45 accounted for a greater proportion of HPV infections in ICCs compared with normal cytological findings (ICC:normal ratios, 3.68, 2.47, and 2.55, respectively). Other high-risk types accounted for important proportions of low- and/or high-grade lesions, but their contribution dropped in ICCs, with ICC:normal ratios in Africa ranging from 0.79 for HPV 33 down to 0.38 for HPV 56. Findings for HPV 16 and HPV 18 in Europe/North America, Asia, and Latin America were compatible with those from Africa. CONCLUSIONS: HPV 16 and HPV 18 in particular, but also HPV 45, at least in Africa, warrant special attention in WHIV. Broad consistency of findings with those in HIV-uninfected population would suggest that the risk stratification offered by partial HPV genotyping tests also have relevance for HIV-positive women.
引用
- Clifford GM, Tully S, Franceschi S, et al. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017. PMID: 28199532. doi:10.1093/cid/cix135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。